(Q46204090)

20 December 2017

title

No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects (English)

1 reference

20 December 2017

author name string

Xin Guo

1

1 reference

20 December 2017

Xiao-Ping Chen

2

1 reference

20 December 2017

Ze-Neng Cheng

3

1 reference

20 December 2017

Xi Luo

4

1 reference

20 December 2017

Ren Guo

5

1 reference

20 December 2017

Lei Chen

6

1 reference

20 December 2017

Jie Chen

7

1 reference

20 December 2017

Bo Chen

8

1 reference

20 December 2017

Jun Peng

9

1 reference

20 December 2017

Yuan-Jian Li

10

1 reference

20 December 2017

publication date

1 January 2009

1 reference

20 December 2017

Clinical Chemistry and Laboratory Medicine

published in

1 reference

20 December 2017

volume

47

1 reference

20 December 2017

page(s)

38-43

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Effect of telmisartan on cholesterol levels in patients with hypertension - Saga Telmisartan Aggressive Research (STAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Telmisartan: a review of its use in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Population pharmacokinetics of an angiotensin II receptor antagonist, telmisartan, in healthy volunteers and hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

The human ATP-binding cassette transporter genes: from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

P-glycoprotein: from genomics to mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

MDR1 gene polymorphism in Japanese patients with schizophrenia and mood disorders including depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Promoter polymorphisms and allelic imbalance in ABCB1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

Rapid Identification of P-glycoprotein Substrates and Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.019

21 January 2018

Identifiers

DOI

10.1515/CCLM.2009.019

1 reference

20 December 2017

PubMed ID

19072027

1 reference

20 December 2017